Stock EKAD PT EKADHARMA INTERNATIONAL TBK
Add to a list
To use this feature you must be a member
Log inSign up

Financials PT Ekadharma International Tbk

Equities

EKAD

ID1000104805

Specialty Chemicals

End-of-day quote INDONESIA S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
234 IDR -1.68% Intraday chart for PT Ekadharma International Tbk -3.31% -5.65%
Mar. 29 PT Ekadharma International Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 PT Ekadharma International Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 597,453 747,689 880,456 1,016,718 978,285 866,481
Enterprise Value (EV) 1 509,863 601,470 570,081 706,645 617,090 447,804
P/E ratio 8.26 x 10.1 x 9.42 x 9.77 x 12.8 x 12 x
Yield 3.51% 3.27% 3.57% 3.44% 3.21% -
Capitalization / Revenue 0.81 x 0.99 x 1.31 x 1.61 x 1.59 x 1.67 x
EV / Revenue 0.69 x 0.79 x 0.85 x 1.12 x 1 x 0.86 x
EV / EBITDA 4.17 x 4.58 x 4.14 x 4.71 x 5.7 x 5.33 x
EV / FCF -63.2 x 8.15 x 2.94 x 74.7 x 9.53 x 10.3 x
FCF Yield -1.58% 12.3% 34% 1.34% 10.5% 9.69%
Price to Book 0.85 x 0.91 x 0.95 x 1.02 x 0.91 x 0.78 x
Nbr of stocks (in thousands) 3,493,875 3,493,875 3,493,875 3,493,875 3,493,875 3,493,875
Reference price 2 171.0 214.0 252.0 291.0 280.0 248.0
Announcement Date 3/28/19 4/26/20 6/29/21 4/18/22 3/29/23 3/29/24
1IDR in Million2IDR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 739,579 758,299 671,541 629,879 614,477 518,359
EBITDA 1 122,289 131,461 137,540 150,027 108,215 83,980
EBIT 1 99,486 108,886 116,258 130,123 91,188 75,174
Operating Margin 13.45% 14.36% 17.31% 20.66% 14.84% 14.5%
Earnings before Tax (EBT) 1 101,455 111,835 123,523 137,720 97,911 87,372
Net income 1 72,355 73,765 93,502 104,410 76,721 71,944
Net margin 9.78% 9.73% 13.92% 16.58% 12.49% 13.88%
EPS 2 20.71 21.11 26.76 29.80 21.96 20.59
Free Cash Flow 1 -8,072 73,782 193,731 9,460 64,721 43,407
FCF margin -1.09% 9.73% 28.85% 1.5% 10.53% 8.37%
FCF Conversion (EBITDA) - 56.12% 140.85% 6.31% 59.81% 51.69%
FCF Conversion (Net income) - 100.02% 207.19% 9.06% 84.36% 60.33%
Dividend per Share 2 6.000 7.000 9.000 10.00 9.000 -
Announcement Date 3/28/19 4/26/20 6/29/21 4/18/22 3/29/23 3/29/24
1IDR in Million2IDR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 87,590 146,220 310,375 310,073 361,195 418,677
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -8,072 73,782 193,731 9,460 64,721 43,407
ROE (net income / shareholders' equity) 10.7% 9.82% 10.6% 10.9% 7.29% 6.55%
ROA (Net income/ Total Assets) 7.54% 7.47% 7.09% 7.24% 4.78% 3.81%
Assets 1 960,052 987,182 1,319,147 1,442,740 1,606,551 1,890,042
Book Value Per Share 2 200.0 236.0 264.0 286.0 309.0 319.0
Cash Flow per Share 2 32.40 46.30 99.60 103.0 112.0 36.20
Capex 1 40,254 25,777 11,157 13,755 9,128 17,351
Capex / Sales 5.44% 3.4% 1.66% 2.18% 1.49% 3.35%
Announcement Date 3/28/19 4/26/20 6/29/21 4/18/22 3/29/23 3/29/24
1IDR in Million2IDR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Specialty Chemicals

1st Jan change Capi.
PT EKADHARMA INTERNATIONAL TBK Stock PT Ekadharma International Tbk
-5.65% 50.4M
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. EKAD Stock
  4. Financials PT Ekadharma International Tbk